A retrospective study on the clinical presentation and treatment outcome of melasma in a tertiary dermatological referral centre in Singapore

Singapore Medical Journal

Volumn 40, Issue 7, 1999, Pages 455-458

  Goh, C L ^a   Dlova, C N ^a  

^a NATIONAL SKIN CENTRE   (Singapore)

Author keywords

Bleaching cream; Chloasma; Skin pigmentation; Sunlight

Indexed keywords

HYDROQUINONE; SUNSCREEN;

ADULT; ARTICLE; CHLOASMA; CLINICAL FEATURE; DISEASE PREDISPOSITION; DRUG DOSAGE FORM; DRUG EFFICACY; FEMALE; HUMAN; MALE; ONSET AGE; SINGAPORE; SKIN PIGMENTATION; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADULT; COSMETICS; FEMALE; HUMANS; MALE; MELANOSIS; MIDDLE AGED; RETROSPECTIVE STUDIES; SINGAPORE; SUNSCREENING AGENTS; TREATMENT OUTCOME;

EID: 0032769224     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Jimbow M, Jimbow K. Pigmentary disorders in Oriental skin. Clin Dermatol 1989; 7:27.
2. Sivayathorn A. Melasma in Orientals. Clin Drug Invest 1995; 10 (Suppl 2):24-40.
3. Fitzpatrick TB. Pathophysiology of hypermelanosis. Clin Drug Invest 1995; 10 (suppl 2): 17-26.
4. Sanchez N, Pathak MA, Sato S, et al. Melasma: a clinical, light microscopic, ultrastructural and immunofluorescence study. J Am Acad Dermatol 1981; 4:698-710.
5. Annual Report 1996, National Skin Centre, Singapore.
6. Resnik S. Melasma induced by oral contraceptive drug. JAMA 1967; 199:601-5.
7. Pathak MA. Clinical and therapeutic aspects of melasma: an overview. In: Fitzpatrick TB, Wick MM, Toda K, (Eds). Brown melanoderma. Tokyo: University of Tokyo Press, 1986; 161-72.
8. Vazquez M, Maldonado H, Benmaman C, et al. Melasma in men, a clinical and histologic study. Int J Dermatol 1988; 27:25-7.
9. Arndt KA, Fitzpatrick TB. Topical use of hydroquinone as a depigmenting agent. JAMA 1965; 194:965-7.
10. Ortonne JP, Bose SK. Pigmentation: dyscromia. In: Baron R, Maibach HI (eds). Cosmetic dermatology. London: M Dunitz, 1994; 278-98.
11. Weinstein GD, Nigra TP, Pochi PE, et al. Topical tretinoin for treatment of photodamaged skin. Arch Dermatol 1991; 127:660-5.
12. Griffiths CEM, Finkel LJ, Titre CM, et al. Topical (retinoic acid improves melasma. A vehicle controlled, clinical trial. Br J Derm 1993; 129:415-21.
13. Nazzaro-Porro M. The use of azelaic acid in hyperpigmentation. Rev Contem Pharmacother 1993; 4:415-23.
14. Verallo-Rowell VM, Verallo V, Graupe K, et al. Double-blind comparation of azelaic acid and hydorquinone in the treatment of melasma. Acta Derm Venereol (Suppl) (Stockh). 1989; 143:58-61.
15. Balina LM, Graupe K. The treatment of melasma - 20% azelaic acid versus 4% hydroquinone cream. Int J Dermatol 1991; 300:893-5.
16. Kligman AM, Willis IA. New formula for depigmenting human skin. Arch Dermatol 1975; 11:40-3.
17. Pathak MA, Fitzpatrick TB, Kraus EW. Usefulness of retinoic acid in the treatment of melasma. J Am Acad Dermatol 1986: 15:894-9.
18. Haas AA, Arndt KA. Selected therapeutic applications of topical tretinoin. J Am Acad Dermatol 1986; 15:870-7.